Anti-IL-6 receptor antibodies for treatment of juvenile idiopathic arthritis

The present disclosure provides compositions and methods for treating and ameliorating the symptoms of systemic juvenile idiopathic arthritis and multi-articular course juvenile idiopathic arthritis using antibodies that specifically bind to human interleukin-6 receptor (hIL-6R). 本公开文本提供了使用特异性结合人白细胞...

Full description

Saved in:
Bibliographic Details
Main Authors BARRETT-COMEL, LISE, FIORI STEFANO, MOMTAHEN, THOMAS, VAN ADELSBERG JANET
Format Patent
LanguageChinese
English
Published 18.03.2022
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure provides compositions and methods for treating and ameliorating the symptoms of systemic juvenile idiopathic arthritis and multi-articular course juvenile idiopathic arthritis using antibodies that specifically bind to human interleukin-6 receptor (hIL-6R). 本公开文本提供了使用特异性结合人白细胞介素-6受体(hIL-6R)的抗体治疗和改善全身型幼年特发性关节炎和多关节病程幼年特发性关节炎的症状的组合物和方法。
Bibliography:Application Number: CN202080024774